AI assistant
MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2012
Dec 6, 2012
65396_rns_2012-12-06_f47a58a4-9968-4b33-9e0f-e880c9ab1119.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [199 x 117] intentionally omitted <==
7 December 2012
Manager, Company Announcements ASX Limited Rialto Towers Level 45, 525 Collins Street MELBOURNE VIC 3000
Dear Sir/Madam
Mayne Pharma Group Limited - Change to option exercise price
On 4 October 2012, Mayne Pharma Group Limited ACN 115 832 963 ( Mayne Pharma ) announced an underwritten pro-rata accelerated non-renounceable entitlement offer of new Mayne Pharma ordinary shares ( Entitlement Offer ).
As a result of the Entitlement Offer, Mayne Pharma announces that in accordance with ASX Listing Rule 6.22, the exercise price of unquoted options issued to certain directors will be reduced by $0.0842 from 17 December 2012.
A summary of the revised exercise price of the unquoted options is set out in the table below.
| Holder | Date optiongranted | Expiry date | Exerciseprice | Number | Newexerciseprice |
|---|---|---|---|---|---|
| Mr I Scholes | 29 October 2009 | 31 December 2012 | $0.27 | 350,000 | $0.1858 |
| Hon R Best | 29 October 2009 | 31 December 2012 | $0.27 | 350,000 | $0.1858 |
| Mr B Mathieson | 29 October 2009 | 31 December 2012 | $0.27 | 350,000 | $0.1858 |
| Dr R Aston* | 29 October 2009 | 31 December 2012 | $0.27 | 1,900,000 | $0.1858 |
| Mr S Richards | 13 February 2012 | 13 February 2019 | $0.345 | 7,500,000 | $0.2608 |
*Dr Roger Aston resigned from the board of directors of Mayne Pharma on 15 February 2012
Yours sincerely
==> picture [153 x 33] intentionally omitted <==
Mark Cansdale Company Secretary
Mayne Pharma Group Limited ABN | 76 115 832 963
a | Level 14, 474 Flinders St, Melbourne Victoria 3000, Australia t | +61 3 8614 7777 f | +61 3 9614 7022 | www.maynepharma.com